Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 118.00 | |
5 mg | In stock | $ 287.00 | |
10 mg | In stock | $ 457.00 | |
25 mg | In stock | $ 753.00 | |
50 mg | In stock | $ 1,060.00 | |
100 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 426.00 |
Description | Rilzabrutinib (PRN1008) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK)(IC50 of 1.3 nM). |
Targets&IC50 | RLK:1.2 nM, EGFR:520 nM, BLK:6.3 nM, BTK:1.3 nM, ErbB4:11.3 nM, Bmx:1.0 nM, Itk:440 nM, TEC:0.8 nM, ErbB2:3900 nM |
Synonyms | PRN1008 |
Molecular Weight | 665.76 |
Formula | C36H40FN9O3 |
CAS No. | 1575596-29-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 130 mg/mL (195.27 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rilzabrutinib 1575596-29-0 Angiogenesis JAK/STAT signaling Others Tyrosine Kinase/Adaptors EGFR BTK HER inhibit PRN-1008 PRN 1008 Inhibitor Btk PRN1008 Bruton tyrosine kinase inhibitor